Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Assets Average (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Assets Average for 12 consecutive years, with $102.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Assets Average rose 63.9% to $102.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $102.3 million, a 63.9% increase, with the full-year FY2025 number at $87.3 million, up 41.74% from a year prior.
  • Assets Average was $102.3 million for Q4 2025 at Niagen Bioscience, up from $94.8 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $102.3 million in Q4 2025 to a low of $46.1 million in Q3 2022.
  • A 5-year average of $62.4 million and a median of $54.9 million in 2024 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: fell 26.93% in 2022, then surged 71.55% in 2025.
  • Niagen Bioscience's Assets Average stood at $59.1 million in 2021, then dropped by 15.7% to $49.9 million in 2022, then rose by 8.75% to $54.2 million in 2023, then increased by 15.08% to $62.4 million in 2024, then skyrocketed by 63.9% to $102.3 million in 2025.
  • Per Business Quant, the three most recent readings for NAGE's Assets Average are $102.3 million (Q4 2025), $94.8 million (Q3 2025), and $86.4 million (Q2 2025).